Össur hf. provided earnings guidance for the year 2022. For the period, the company's organic sales growth is expected to be in the range of 6% to 9%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.95 DKK | -0.52% | -2.03% | +5.28% |
04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
04-23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.28% | 1.8B | |
-11.87% | 21.14B | |
+2.99% | 17.59B | |
+10.27% | 10.13B | |
-8.97% | 2.28B | |
+34.04% | 1.65B | |
+24.42% | 652M | |
0.00% | 385M | |
+29.81% | 150M | |
+24.86% | 93.16M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur Hf. Provides Earnings Guidance for the Year 2022